TDACU (Translational Development Acquisition) Accounts Payable: $0.49 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TDACU Translational Development Acquisition Corp TDACU
17 GF Score
Price $12.57
! 3 Warning Signs
View Full Analysis

What is Translational Development Acquisition Accounts Payable?

Translational Development Acquisition TDACU 17 Accounts Payable is $0.49 Mil as of Jun. 2026. GuruFocus rates TDACU with a GF Score™ of 17/100. The stock has 3 warning signs investors should review.

Translational Development Acquisition's Accounts Payable for the quarter that ended in Jun. 2026 was $0.49 Mil.

Translational Development Acquisition's quarterly Accounts Payable increased from Dec. 2025 ($0.16 Mil) to Mar. 2026 ($0.22 Mil) and increased from Mar. 2026 ($0.22 Mil) to Jun. 2026 ($0.49 Mil).

Translational Development Acquisition's annual Accounts Payable increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.02 Mil) and increased from Dec. 2024 ($0.02 Mil) to Dec. 2025 ($0.16 Mil).

Translational Development Acquisition Accounts Payable Related Terms

Translational Development Acquisition Accounts Payable Historical Data

* Premium members only.

The historical data trend for Translational Development Acquisition's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Translational Development Acquisition Accounts Payable Chart

Translational Development Acquisition Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Payable
0.00 0.00 0.02 0.16

Translational Development Acquisition Quarterly Data
May22 Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.17 0.16 0.22 0.49
TDACU
17GF Score
Translational Development Acquisition Corp TDACU
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Translational Development Acquisition Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.49 Mil mean?
Translational Development Acquisition (TDACU) has a Accounts Payable of $0.49 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Translational Development Acquisition and its competitors.
Is Translational Development Acquisition's Accounts Payable too high?
Translational Development Acquisition's current Accounts Payable is $0.49 Mil. Overall, Translational Development Acquisition has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Translational Development Acquisition's Accounts Payable compare to PALO and HAVA?
Translational Development Acquisition's Accounts Payable of $0.49 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Diversified Financial Services company?
A good Accounts Payable depends on the Diversified Financial Services industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Translational Development Acquisition and its competitors. Translational Development Acquisition's current Accounts Payable is $0.49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Translational Development Acquisition stock overvalued right now?
Translational Development Acquisition (TDACU) has a current Accounts Payable of $0.49 Mil. The current Accounts Payable is $0.49 Mil. Translational Development Acquisition's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Translational Development Acquisition (TDACU), the current Accounts Payable is $0.49 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Translational Development Acquisition Business Description

Other Exchanges TDAC:USA
Address 52 East 83rd Street, New York, NY, USA, 10028
Translational Development Acquisition Corp is a newly organized blank check company.
17GF Score

Get the complete analysis for TDACU

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.57
Price